Immunogenic agent therapy using plasmapheresis or exchange...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 39/00 (2006.01) A61K 39/40 (2006.01) A61K 39/42 (2006.01) C07K 16/10 (2006.01) A61M 1/34 (2006.01)

Patent

CA 2483551

Lowering the level of antibody or complement in the blood of a subject by plasmapheresis or exchange transfusion prior to administering an immunogenic therapeutic agent containing a foreign epitope reduces the immune response of the subject to the therapeutic agent.

Selon l'invention, la réduction du taux d'un anticorps ou d'un complément dans le sang d'un sujet par plasmaphérèse ou exsanguinotransfusion, avant l'administration d'un agent thérapeutique immunogène contenant un épitope étranger, permet de réduire la réponse immunitaire du sujet audit agent thérapeutique.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Immunogenic agent therapy using plasmapheresis or exchange... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Immunogenic agent therapy using plasmapheresis or exchange..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Immunogenic agent therapy using plasmapheresis or exchange... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1460305

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.